Top Recruiting Trials
20 actively recruiting studies
Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ®
Idorsia Pharmaceuticals Ltd.
n=785
IQVIA US Office
Durham, North Carolina
Intervention DRUG: Daridorexant — Dosing and treatment duration of QUVIVIQ as part of this observational study is at the discretion of the healthcare prov...
Eligibility Ages 15 Years – 50 Years, FEMALE only
Integration of Cognitive Processing Therapy and Relapse Prevention for Alcohol Use Disorder and PTSD
Texas A&M University
n=200
Medical University of South Carolina
Charleston, South Carolina
Intervention BEHAVIORAL: Cognitive Processing Therapy + Relapse Prevention — Cognitive-Behavioral Therapy that integrates Cognitive Processing Therapy for PTSD with Relapse Prevention for alcohol u...
Eligibility Ages 18 Years
Bruxism, Anxiety, and Periodontal Status Among Dental Students
Al-Hawash Private University
n=100
Al-Hawash Private University, Faculty of Dentistry
Homs
Eligibility Ages 18 Years
Efficacy of a Multicomponent Intervention on Cognitive Function for the Caregiver-patient Dyad
Universidad de Santander
n=102
Universidad de Santander / Universidad Manuela Beltrán /FOSCAL
Bucaramanga, Santander Department
Intervention OTHER: Multi-component, transdisciplinary and multifocal intervention for the cognition — Multi-component intervention (12 weeks, twice/week, with professional support at home)
Physical activity for the patien...
Eligibility Ages 55 Years
iCBT for Seniors With Depression in Primary Care
Göteborg University
n=390
University of Gothenburg
Gothenburg
Intervention BEHAVIORAL: iCBT for depression — iCBT depression program with minimal therapist contact offered within 14 days from inclusion and with a duration of 10-1...
Eligibility Ages 65 Years
The Effects of Propranolol and Hydrocortisone on Military-Relevant Performance Outcomes
Walter Reed Army Institute of Research (WRAIR)
n=88
Sleep Research Center (SRC), Walter Reed Army Institute of Research
Silver Spring, Maryland
Intervention DRUG: Propranolol — An administration of a 40-mg propranolol capsule immediately after tarantula exposure
Eligibility Ages 18 Years – 40 Years
Characterizing Dopamine Receptor Binding in Treatment Resistant Depression
Unity Health Toronto
n=45
Unity Health Toronto
Toronto, Ontario
Intervention DIAGNOSTIC_TEST: PET scans — PET scans and PHNO scans
Eligibility Ages 25 Years – 55 Years
Longitudinal Cognitive Assessment by BoCA
Alzheimer's Light LLC
n=10000
Andrey Vyshedskiy
Miami, Florida
Intervention DIAGNOSTIC_TEST: Boston Cognitive Assessment (BoCA) — The Boston Cognitive Assessment (BoCA) is a self-administered online test intended for longitudinal cognitive monitoring...
Eligibility Ages 50 Years
Targeting Repetitive Behaviors in Autism Spectrum Disorder Via Transcranial Direct Current Stimulation
Bambino Gesù Hospital and Research Institute
n=78
Bambino Gesù Children Hospital
Rome, Italy
Intervention DEVICE: Active HD-tDCS over pre-SMA — Active cathodal HD-tDCS over pre-SMA cortex will be delivered for 10 days (3 sessions per week). The 4 × 1 montage using...
Eligibility Ages 8 Years – 13 Years
Virtual Reality for Recovery After Intensive Care (PICS)
University of Minho
n=51
Centro Hospitalar Universitário São João
Porto, Porto District
Intervention DEVICE: Immersive VR Multi-Domain Rehabilitation — A bedside multi-domain rehabilitation program using a head-mounted display. Participants perform 6 gamified tasks target...
Eligibility Ages 18 Years
Retinal Vessel Leakage in Cerebral Small Vessel Disease
University of Edinburgh
n=40
NHS Lothian
Edinburgh
Intervention DIAGNOSTIC_TEST: Fundus fluorescein angiography, with ultrawide field retinal imaging — Intravenous injection of sodium fluorescein for angiography of retinal blood vessels
Eligibility Ages 18 Years
Personalized Ultrasonic Brain Stimulation for Depression (R61)
Brian Mickey
n=30
University of Utah
Salt Lake City, Utah
Intervention DEVICE: LTFUS to SCC — Low-intensity transcranial focused ultrasound delivered to subgenual cingulate cortex
Eligibility Ages 18 Years – 65 Years
COpenhagen Magnetic Personalized Accelerated Brain Circuit Therapy for Treatment Resistant Depression
Danish Research Centre for Magnetic Resonance
n=78
Centre of Neuropsychiatric Depression Research
Glostrup Municipality
Intervention DEVICE: MagVenture XP Orange Stimulator and active side of MagVenture COOL-B65 coil. — Intermittent theta burst stimulation (iTBS) targeting the left dorsolateral prefrontal cortex (DLPFC) will be administer...
Eligibility Ages 18 Years – 95 Years
Shared Decision Making in PTSD Treatment
The University of Texas Health Science Center at San Antonio
n=200
Carl R. Darnall Army Medical Center (CRDAMC)
Fort Cavazos, Texas
Intervention BEHAVIORAL: Prolonged Exposure Therapy — PE is a cognitive-behavioral treatment for PTSD that is typically delivered in ten 90-minute sessions . For the current ...
Eligibility Ages 18 Years
Interleaved TMS-fMRI in Ultra-treatment Resistant Depression
Sunnybrook Health Sciences Centre
n=88
Sunnybrook Health Sciences Centre
Toronto, Ontario
Intervention DEVICE: rTMS — Accelerated iTBS treatment
Eligibility Ages 20 Years – 65 Years
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
Autobahn Therapeutics, Inc.
n=230
Autobahn Site #131
Birmingham, Alabama
Intervention DRUG: ABX-002 — ABX-002 oral solution in 1-mL cyclic olefin polymer prefilled syringes, taken on an empty stomach first thing in the mor...
Eligibility Ages 18 Years – 65 Years
Oxytocin Effects on Bone in Children With Autism Spectrum Disorder
Elizabeth Austen Lawson
n=96
Massachusetts General Hospital
Boston, Massachusetts
Intervention DRUG: 1. Intranasal oxytocin spray — 30 IU, twice daily for 12 months in the experimental arm in double-blinded phase
Eligibility Ages 6 Years – 18 Years
Functional Near-infrared Spectroscopy for Anxiety Monitoring and Neurofeedback.
National Taiwan University Hospital
n=232
National Taiwan University Hospital
Taipei
Intervention DEVICE: AI-fNIRS neurofeedback device — The device, with AI-fNIRS signals serving as brain monitor to indicate the level of anxiety, provides mindfulness traini...
Eligibility Ages 18 Years
Pancreatic Polypeptide as a Modulator of Amylin- Induced Satiety in Healthy Humans
University Hospital, Gentofte, Copenhagen
n=18
Center for Clinical Metabolic Research, Gentofte Hospital
Hellerup, Capital Region
Intervention DRUG: Amylin (Pramlintide) — This a one of the pancreatic hormones investigated in this study. Pramlintide is used a surrogate for amylin due to the ...
Eligibility Ages 18 Years – 65 Years, MALE only
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Alkermes, Inc.
n=256
Alkermes Investigator Site
Phoenix, Arizona
Intervention DRUG: ALKS 2680, 4mg — Oral tablet containing 4 mg of ALKS 2680 for once daily administration
Eligibility Ages 18 Years – 70 Years